Windlas Biotech Ltd.'s market cap is currently ₹19.52B. The company's EPS TTM is ₹8.428; its P/E ratio is 29.66; and it has a dividend yield of 0.63%. Windlas Biotech Ltd. is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
